GALMED PHARMACEUTICALS LTD. Depreciation
GALMED PHARMACEUTICALS LTD. (GLMD) reported Depreciation of $80.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-04-02
| Period end | Depreciation 12 month |
|---|---|
| 2024-12-31 | $80.00K 20-F · filed 2025-04-02 |
| 2023-12-31 | $30.00K 20-F · filed 2025-04-02 |
| 2022-12-31 | $60.00K 20-F · filed 2025-04-02 |